Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Cytokine-Driven Janus Kinase Signal Transducer and Activator of Transcription Pathway Hyperactivity Predicts Disease Severity in Pediatric FSGS.
Journal: Kidney360
Published: June 16, 2025
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 14, 2025
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial.
Journal: Kidney international reports
Published: December 11, 2023
Diagnosis and management of primary hyperoxalurias: best practices.
Journal: Pediatric nephrology (Berlin, Germany)
Published: November 13, 2023
Updated consensus guidelines on the management of Phelan-McDermid syndrome.
Journal: American journal of medical genetics. Part A
Published: February 14, 2023
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1.
Journal: Kidney international reports
Published: November 12, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Journal: The New England journal of medicine
Published: March 31, 2021
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring.
Journal: Journal of neurodevelopmental disorders
Published: May 27, 2020
Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease.
Journal: Pediatric nephrology (Berlin, Germany)
Published: October 24, 2019
Secondhand smoke exposure and higher blood pressure in children and adolescents participating in NHANES.
Journal: Preventive medicine
Published: September 05, 2019
Last Updated: 09/26/2026